Ventricular Assist Devices Market
By Product (Left Ventricular Assistive Device (LVAD), Right Ventricular Assistive Device (RVAD), and Biventricular Assistive Device),
By Application (Bridge To Transplant (BTT), Bridge To Recovery (BTR), Bridget To Candidacy (BTC) and Destination Therapy (DT)),
By Type (Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices),
By Flow (Pulsatile Flow and Continuous Flow),
By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa):
Ventricular Assist Devices Market - Global Analysis and Forecast 2023-2033
The global Ventricular assist devices market showcased a revenue of USD 1.53 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 9% over the forecast period of 2023-2033.
Russia-Ukraine War Impact
Market Scope
About the Market
Impact of COVID-19
Global Economic Slowdown
Market Dynamics
Driver
Restrain
Opportunity
Recent Developments
Synopsis
How is this report helpful
FAQ's
Report Coverage
Related Reports
Ventricular Assist Devices are specialized Implants meant to keep heat pumping. These devices are used when a Heart is in a failing condition. These devices are applied during Heart transplants as temporary or permanent treatment where a heart transplant is not possible. The rise in the Geriatric population coupled with the increase in cardiovascular disorders are primary factors boosting the growth of the Ventricular Assist Device market.
Heart failure is a condition that can be only managed by medicines when in a milder stage; eventually, severe heart failure would either require pumping devices or a total Heart transplant. Ventricular assist devices have been used for both scenarios, making them an inevitably required tool for heart failure cases. A VAD may be temporarily used during the transplant while a donor becomes available. Two years ago, American Heart Association reported that the number of people diagnosed with heart failure is increasing. They also projected the trend to rise by 46 percent by 2030, resulting in more than 8 million people with heart failure. Heart failure and other factors contributing to the rising prevalence of Heart transplant cases are also fuelling the need for the Ventricular assist devices market.
Further, the rise in unhealthy life practices such as smoking, drinking, late-night working, or sleep-disrupting activities is also fuelling factors for the rising prevalence of heart disorders. According to a review by Annals of Cardiothoracic Surgery, advancements in immunosuppression and personalized medicine would be key growth factors for rising Heart Transplants. This indicates an overall growth for the ventricular assist device market as well. On the other hand, failures of heart transplants or deficiency of donors can also propel the growth of the ventricular assist devices market as it could then be used as a permanent treatment. Furthermore, Regulatory guidelines are also making it flexible to innovate and introduce new innovations. For instance, in 2016, the U.S congress introduced the Breakthrough Devices program, which opened ways for flexibility in development and innovations for serious illnesses. These trends and Developments collectively support the market growth for ventricular assist devices.
Impact of Russia-Ukraine War on Ventricular Assist Device: Market Scope
There has been a notable impact of Russia-Ukraine war on the European ventricular assist device market followed by its impact at the global level. Extreme environments in Russian and Ukrainian region has resulted in increasing cases of heart diseased and strokes, generating the demand of ventricular assistive device. Furthermore the disruption in supply chain and increasing tax implication in cross border trading has increased the overall cost of acquisition and operation of ventricular assistive devices in the European region. Fleeing of medical staff, doctors, and skilled professional from the Russian and Ukrainian region due the ongoing war has also impacted the market negatively,
Ventricular Assist Device: Market Scope
The Ventricular assist device market is divided into four segments Product, Application, Type, and flow. Furthermore, these segments are subdivided into respective categories and cross-referenced to North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa for regional analysis. The product segment is further categorized into Left Ventricular Assistive Device (LVAD), Right Ventricular Assistive Device (RVAD), and Biventricular Assistive Device (BIVAD). The Application segment is segregated into Bridge To Transplant (BTT), Bridge To Recovery (BTR), Bridge to Candidacy (BTC), and Destination Therapy (DT). Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices bifurcate the type segment of the Ventricular assist device market. With respect to flow, the industry is analyzed by Pulsatile Flow and Continuous Flow. Each of these segments is further classified into regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The historical dataset of 2018-2022 is provided in the report, whereas the forecast period of 2023-2033 is offered.
Left Ventricular Assistive Device (LVAD) would capture the highest market share
Heart failure is a complicated condition where the inability of heart muscles to pump blood effectively in the systemic aorta creates congestion in the left ventricle. The left ventricle is thicker, more directly connected to the systemic circulation, and experiences greater congestion than the right ventricle. This biological aspect is responsible for more patients being affected adversely in the left ventricle than in the right ventricle. Recent trends have observed more support for left ventricular assist devices in the market. For instance, a recent study by Michigan Medicine found that growth in LVAD centers might result in reduced heart transplant procedures. This is because patients would rely more on device-assisted pumping than going for a full heart transplant. Further Rise in the geriatric population and increasing chronic disorders would propel the market growth for Left ventricular assisted devices.
Bridge to Transplant (BTT) within the Application Segment to capture the highest market share
"Bridge to transplant" is the approach where a ventricular assist device is implanted only until a suitable donor is finally made available. In such scenarios, ventricular assist devices support the temporary pumping of a failing heart until a new heart is transplanted. Bridge to Transplant application is expected to witness growth due to improvement in Heart transplant success rates. Where availability of donors might remain an uncertain factor, it is for sure that improvements in immunosuppression would hike the chances of success during Transplant procedures that manage to take place. Current procedures prioritize most urgent patients over low urgency patients to manage mortality rates. Also, current and developing procedures are improvising in donor-recipient matching and widening the donor pool by accommodating high-risk donors with comorbidities.
Transcutaneous Ventricular Assist Devices witness the highest growth rate
Transcutaneous ventricular assist devices are usually external, where a pump outside the body is connected to the heart inside. The pump is external and not surgically placed inside like an implant. Transcutaneous assist devices are more suitable for the geriatric population and really weak or sick patients who can't endure heavy surgical procedures. The pump, not being placed inside, only act as support and is thus suitable as a bridge to transplant rather than permanent treatment. The rise in the geriatric population and a sharp rise in cardiovascular ailments propelled the market demand for transcutaneous ventricular assist devices.
Continuous Flow Model to gain the highest market share
In alignment with the complexities of Heart failure and the possible severity of the condition, it has been observed that continuous models gain more market preference than pulsatile flow models. Improvements in the functioning and innovation of devices also fuel more market growth for continuous flow models. According to some studies, continuous flow models give better outcomes for patients suffering from end-stage renal disease, which is often linked with advanced heart failure. Renal impairment is a 'follow-along' disorder that happens mostly with cardiovascular ailments, essentially improved by continuous flow models compared to pulsatile flow models.
Asia-Pacific will witness the highest growth rate in the forecast period
Asia-Pacific is the Hotspot for increased penetration of Ventricular assists devices. Increased investments in medical innovations and initiatives are the primary factors aiding in the growth of this region's ventricular assist device market. The rising geriatric population and increase in unhealthy lifestyle patterns, coupled with more instances of cardiovascular ailments, further drive the market growth. For instance, engineers from IIT Kanpur, India, are building an affordable and lasting artificial Heart to improve heart patients' treatment dynamics.
Impact of COVID-19 on the Ventricular Assist Device Market Industry
COVID-19 accelerated the instances of Heart ailments and thus propelled cardiovascular disorders; however, lack of beds and staffing resulted in the decline of actual Heart surgeries. This implies that Heart transplants or ventricular assist device transplants experienced a negative impact during COVID while simultaneously gearing up for a positive impact post-COVID. Doctors were increasingly looped in for virus-infected patients, and thus, facilities for surgeries were reduced greatly during widespread infection. Stress and disruption in lifestyle caused an increased number of Heart patients simultaneously, creating more markets for Heart surgeries post-pandemic.
Ventricular Assist Devices: Market Dynamics
The market dynamics section of the report covers an in-depth analysis of drivers, restraints, and opportunities impacting the Ventricular assist devices market. The report also encompasses major market strategies practiced by the industry, followed by patent analysis, product analysis, competitive benchmarking of companies, PORTER and PESTLE analysis of the Ventricular assist devices industry, pricing analysis, and geographic competitiveness to provide a detailed understanding. The major players operating in the market are Abbott Laboratories, Abiomed, Medtronic, Berlin Heart GmbH, Calon Cardio, CardioDyme, Jarvik Heart Inc., Medtronic plc, ReliantHeart Inc., SynCardia Systems and Terumo Medical Corporation. These companies cumulatively hold most of the Ventricular assist devices market share and actively undergo strategic development such as new product launches, mergers, collaborations, business expansion, acquisition, and long-term contracts to ensure market penetration. These companies also largely focus on research and development to gain technological competitiveness in the market. A detailed analysis of these companies is offered in the report.
Drivers: Increased heart failure and transplant procedures
According to the statistics recorded by Jamacardiology, there is a 26 to 40 percent risk of developing Heart failure during the entire lifetime of adults aged 45 or more years old. In 2012, cardiovascular disorders extracted a total expenditure of $31 billion. The estimated health expenditure has been rising since then. These trends indicate the rising prevalence of heart failure in the forthcoming years. Increased cases of Heart surgeries, transplants, or heart failure would thus drive the market growth for ventricular assist devices.
Restrain: Side effects or complications due to surgical procedures
Heart surgeries are complex procedures that might be heavy or exhausting for the patient. Depending upon the severity, complications, and other dysfunctional organs, a patient might be more suspected of developing side effects than an average patient. The instances of side effects increase with the complexity of disorders. Also, more complex disorders are becoming increasingly prevalent due to unhealthy life patterns. For instance, Florey Institute of Neuroscience and Mental Health recently dug deeper into brain injury caused by Heart surgeries. Another study indicated that Heart disease treatment must change with changing or increasing age so as to suit diverse patients according to their body's needs.
Opportunity: Technological Advancements
In a quest to reduce complications and improve heart efficacy, the market is now divulging more technologically advanced opportunities. For instance, magAssist Inc recently attended the 2022 Critical Heart Disease Congress - International Society for Mechanical Circulatory Support Parallel Forum. The Chinese company demonstrated various research and technological innovation ideas. It gained recognition for bringing development in the critical heart care field. More pharmaceutical and medical devices firms, such as Abbott, are increasingly investing in innovative product development to make space in market competition.
Ventricular assist devices Market: Recent Developments
- IIT Kanpur, India, introduced its vision of developing 'hridyantara' (translating to Heart star) along the lines of an innovative medical devices program for developing the world's most advanced left ventricular assist device.
- An innovative artificial heart device combining rocket and medical science, named "Rocket Heart," gained approval for market launch by National Medical Products Administration. Researchers and professionals from the China Academy of Launch Vehicle Technology developed the product in China.
National Heart, Lung, and Blood Institute recently made efforts towards the development of a smarter pump for heart failure. The innovative product is designed to pump in sync with the patient's heartbeats. This is medically linked with reduced bleeding or stroke chances. - Michigan Medicines is developing a very comprehensive certification exam for Professionals who treat VAD patients. The certification exam is meant to give recognition to those professionals who exhibit exquisite knowledge. This would result in increased patient faith in the medical professional attending them and a subsequent rise in patient adherence.
Ventricular Assist Devices Market: Synopsis
The Ventricular assist devices market study offers revenue and growth data sets of segments provided at the global, regional, and country levels. The report offers the historical data set of 2018-2022 and the forecast period of 2023-2033. For analysis, Quadrant Market Insights (QMI) has segregated the Ventricular assist devices market into four major segments as follows:
By Product
- Left Ventricular Assistive Device (LVAD)
- Right Ventricular Assistive Device (RVAD)
- Biventricular Assistive Device (BIVAD)
By Application
- Bridge To Transplant (BTT)
- Bridge To Recovery (BTR)
- Bridget To Candidacy (BTC)
- Destination Therapy (DT)
By Type
- Transcutaneous Ventricular Assist Devices
- Implantable Ventricular Assist Devices
By Flow
- Pulsatile Flow
- Continuous Flow
The regional analysis of the ventricular assist devices market is as follows:
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Chile
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Israel
Key players operating in the ventricular assist devices industry are:
- Abbott Laboratories
- Abiomed, Medtronic
- Berlin Heart GmbH
- Calon Cardio
- CardioDyme
- Jarvik Heart Inc.
- Medtronic plc
- ReliantHeart Inc.
- SynCardia Systems
- Terumo Medical Corporation
Ventricular Assist Device Market: Who Should Purchase, and How It Will Help Readers
- The report is best suited for top-level decision-makers, individuals who are supposed to take a leadership role or require market research to start a business, independent researchers, research institutes, and anyone who wishes to gain detailed strategic insights into the ventricular assist device market.
- This report provides a qualitative and quantitative analysis of the market segments, current trends, estimations, and dynamics of the ventricular assist device market analysis from 2018 to 2033 to identify the prevailing market opportunities.
- Market research and information related to key drivers, restraints, and opportunities are offered.
- Porter's five forces and PESTLE analysis highlight the potency of buyers and suppliers to enable stakeholders' market profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the ventricular assist device segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional and global ventricular assist device industry trends, key players, market segments, application areas, and market growth strategies.
- The report offers insights from primary interviews and CXOs of major industry players. It also offers a comprehensive contact and event repository to ensure future collaborations among industry stakeholders.
Ventricular Assist Device Market: Frequently Asked Questions (FAQ)
Q: How big is the ventricular assist device market?
A: The global Ventricular assist devices market showcased a revenue of USD 1.53 billion in 2022 and is projected to witness a compounded annual growth rate (CAGR) of more than 9% over the forecast period of 2023-2033.
Q: Does the report have several ventricular assist device numbers bifurcated by segments and regions?
A: The report offers a total number of ventricular assist device market , further bifurcated into segments and regions. Please refer to the TOC page for more information.
Q: What are the major trends in the ventricular assist device market?
A:Rise in the geriatric population, increasing prevalence of heart failures, advancements and improvements in heart transplants, and innovation in ventricular assist devices are the major factors defining the market of Ventricular assist devices within the forecast period.
Q: How can I get the sample Report on the ventricular assist device market?
A: The ventricular assist device market report sample can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report
Q: Is it possible to purchase a specific or customized report as per my needs
A: Yes, it is possible to purchase a specific part of the report or edit the scope of the report at your convenience. Feel free to drop us the mail/talk to our customer support or schedule a conversation to procure a customized report.
Report Coverage
- Product
- Application
- Type
- Flow
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Rising cases of heart failure followed by advancements in transplant procedures
- Introduction of new technologies in ventricular assist device market
- Lack of skilled labour across the globe to perform such operations
Abbott Laboratories, Abiomed, Medtronic, Berlin Heart GmbH, Calon Cardio, CardioDyme, Jarvik Heart Inc., Medtronic plc, ReliantHeart Inc., SynCardia Systems and Terumo Medical Corporation. Ltd.
1. Introduction
1.1 Report Description
1.1.1 Definition
1.1.2 Abbreviations
1.2 Key Market Segments
1.3 Benefits to Stakeholders
1.4 Research Methodology
1.4.1 Market Scoping
1.4.1.1 Problem Identification
1.4.1.2 Defining the Market
1.4.2 Market Estimation
1.4.2.1 Data Mining
1.4.2.2 Product Analysis
1.4.2.3 Application Analysis
1.4.2.4 Market Engineering and Forecasting
1.4.2.4.1 Bottom-up Demand Side
1.4.2.4.2 Bottom-up Supply side
1.4.3 Market Authentication
1.4.3.1 Data Triangulation
1.4.3.1.1 Top-down Supply Side
1.4.3.1.2 Top-down Demand Side
1.4.3.1.3 Data Triangulation
1.4.3.2 Primary Insights and Industry feedback
1.4.4 Report Writing
2. Executive Summary
2.1 Market Snapshot
2.2 Macro Trends, Global Economic Factors and Import/Export Insights
2.3 Primary Insights
2.4 Product Insights
2.5 Application Insights
2.6 Type Insights
2.7 Flow Insights
2.8 Regional Insights
3. Market Overview
3.1 Market Segment and Scope
3.2 Top Investment Pockets
3.3 Key Strategic Initiatives
3.4 Ventricular Assist Device Market Industry Ecosystem
3.5 Market Evolution
3.6 Patent Analysis
3.7 Technology Landscape
3.8 Regulatory Infrastructure
3.9 Porter’s Analysis
3.9.1 Bargaining Power of Buyer
3.9.2 Bargaining Power of Supplier
3.9.3 Threat of New Entrants
3.9.4 Threat of Substitutes
3.9.5 Industry Rivalry
3.10 PESTLE Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.2 Restrains
3.11.3 Opportunities
3.12 Impact of COVID-19 on Ventricular Assist Device Market
3.13 Russia-Ukraine War Impact on Ventricular Assist Device Market
3.14 Growth Share Matrix
3.15 Ventricular Assist Device Market Quadrant
4. Ventricular Assistive Device Market, By Product
4.1 Major Impacting Factors, By Product
4.1.1 Key Market Trends and Growth Factors
4.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.2 Left Ventricular Assistive Device (LVAD)
4.2.1 Key Market Trends and Growth Factors
4.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.3 Right Ventricular Assistive Device (RVAD)
4.3.1 Key Market Trends and Growth Factors
4.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
4.4 Biventricular Assistive Device B(IVAD)
4.4.1 Key Market Trends and Growth Factors
4.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
4.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5. Ventricular Assistive Device Market, By Application
5.1 Major Impacting Factors, By Application
5.1.1 Key Market Trends and Growth Factors
5.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.2 Bridge To Transplant (BTT)
5.2.1 Key Market Trends and Growth Factors
5.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.3 Bridge To Recovery (BTR)
5.3.1 Key Market Trends and Growth Factors
5.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.4 Bridget To Candidacy (BTC)
5.4.1 Key Market Trends and Growth Factors
5.4.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.4.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
5.5 Destination Therapy (DT)
5.5.1 Key Market Trends and Growth Factors
5.5.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
5.5.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6. Ventricular Assistive Device Market, By Type
6.1 Major Impacting Factors, By Type
6.1.1 Key Market Trends and Growth Factors
6.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.2 Transcutaneous Ventricular Assist Devices
6.2.1 Key Market Trends and Growth Factors
6.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
6.3 Implantable Ventricular Assist Devices
6.3.1 Key Market Trends and Growth Factors
6.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
6.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7. Ventricular Assistive Device Market, By Flow
7.1 Major Impacting Factors, By Flow
7.1.1 Key Market Trends and Growth Factors
7.1.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.1.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.2 Pulsatile Flow
7.2.1 Key Market Trends and Growth Factors
7.2.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.2.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
7.3 Continuous Flow
7.3.1 Key Market Trends and Growth Factors
7.3.2 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
7.3.3 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8. Ventricular Assistive Device Market, By Region
8.1 Global Market Trends and Growth Factors
8.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.6 Market Size and Forecast, by Region, 2018-2033, (USD Billion)
8.7 North America
8.7.1 Key Market Trends and Growth Factors
8.7.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.7.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.7.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.7.7 U.S.
8.7.7.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.7.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.7.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.7.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.7.8 Canada
8.7.8.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.7.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.8.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.8.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.7.9 Mexico
8.7.9.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.7.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.7.9.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.7.9.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8 Europe
8.8.1 Key Market Trends and Growth Factors
8.8.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.8.7 UK
8.8.7.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.7.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.7.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.8 Germany
8.8.8.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.8.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.8.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.9 France
8.8.9.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.9.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.9.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.10 Russia
8.8.10.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.10.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.10.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.11 Italy
8.8.11.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.11.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.11.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.11.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.8.12 Rest of Europe
8.8.12.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.8.12.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.8.12.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.8.12.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9 Asia-Pacific
8.9.1 Key Market Trends and Growth Factors
8.9.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.9.7 China
8.9.7.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.7.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.7.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9.8 India
8.9.8.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.8.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.8.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9.9 Japan
8.9.9.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.9.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.9.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9.10 Australia
8.9.10.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.10.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.10.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.9.11 Rest of Asia-Pacific
8.9.11.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.9.11.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.9.11.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.9.11.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.10 Latin America
8.10.1 Key Market Trends and Growth Factors
8.10.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.10.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.10.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.10.7 Brazil
8.10.7.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.10.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.7.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.7.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.10.8 Argentina
8.10.8.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.10.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.8.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.8.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.10.9 Mexico
8.10.9.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.10.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.9.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.9.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.10.10 Chile
8.10.10.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.10.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.10.10.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.10.10.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.11 Middle East and Africa
8.11.1 Key Market Trends and Growth Factors
8.11.2 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.11.3 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.4 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.5 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.11.6 Market Size and Forecast, by Country, 2018-2033, (USD Billion)
8.11.7 South Africa
8.11.7.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.11.7.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.7.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.7.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.11.8 UAE
8.11.8.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.11.8.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.8.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.8.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.11.9 Saudi Arabia
8.11.9.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.11.9.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.9.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.9.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
8.11.10 Israel
8.11.10.1 Market Size and Forecast, by Product, 2018-2033, (USD Billion)
8.11.10.2 Market Size and Forecast, by Application, 2018-2033, (USD Billion)
8.11.10.3 Market Size and Forecast, by Type, 2018-2033, (USD Billion)
8.11.10.4 Market Size and Forecast, by Flow, 2018-2033, (USD Billion)
9. Competitive Benchmarking & Company Profiles
9.1 Competitive Benchmarking
9.1.1 Company Market Share
9.1.2 Product Mapping
9.1.3 Competitive Heat map
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Product Offering
9.2.4 Strategic Initiatives
9.2.5 SWOT
9.2.6 Ansoff Matrix
9.3 Abiomed, Medtronic
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Product Offering
9.3.4 Strategic Initiatives
9.3.5 SWOT
9.3.6 Ansoff Matrix
9.4 Berlin Heart GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Product Offering
9.4.4 Strategic Initiatives
9.4.5 SWOT
9.4.6 Ansoff Matrix
9.5 Calon Cardio
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Product Offering
9.5.4 Strategic Initiatives
9.5.5 SWOT
9.5.6 Ansoff Matrix
9.6 CardioDyme
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Product Offering
9.6.4 Strategic Initiatives
9.6.5 SWOT
9.6.6 Ansoff Matrix
9.7 Jarvik Heart Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Product Offering
9.7.4 Strategic Initiatives
9.7.5 SWOT
9.7.6 Ansoff Matrix
9.8 Medtronic plc
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Product Offering
9.8.4 Strategic Initiatives
9.8.5 SWOT
9.8.6 Ansoff Matrix
9.9 ReliantHeart Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Product Offering
9.9.4 Strategic Initiatives
9.9.5 SWOT
9.9.6 Ansoff Matrix
9.10 SynCardia Systems
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Product Offering
9.10.4 Strategic Initiatives
9.10.5 SWOT
9.10.6 Ansoff Matrix
9.11 Terumo Medical Corporation
9.11.1 Company Overview
9.11.2 Financial Analysis
9.11.3 Product Offering
9.11.4 Strategic Initiatives
9.11.5 SWOT
9.11.6 Ansoff Matrix
10. Industry Connects and Upcoming Seminars
